CDK19通过抑制p53介导的p21转录调控造血干细胞与急性髓系白血病细胞的增殖
该研究探讨CDK19在造血干细胞(HSC)和急性髓系白血病(AML)细胞增殖调控中的作用。发现CDK19(而非CDK8)在小鼠HSC中相对富集,增殖应激后表达增加更显著;SenexinB抑制HSC增殖与自我更新,CDK19敲除HSC表型类似;CDK19与p53互作抑制p53介导的p21转录,p53抑制剂PFTβ部分挽救CDK19缺失HSC缺陷;SenexinB显著抑制AML细胞增殖。
要点
- CDK19而非CDK8在小鼠HSC中相对富集,增殖应激后表达增加更显著。
- SenexinB处理损害HSC增殖与自我更新,CDK19敲除HSC表型类似。
- CDK19通过抑制p53介导的p21转录调控HSC与AML细胞增殖。
核心结论
- CDK19通过p53-p21通路参与调控HSC和AML细胞增殖,揭示正常与恶性造血细胞细胞周期调控的新机制。
研究设计与样本
- 基础实验研究,使用小鼠HSC、CDK19敲除小鼠及AML细胞,未报告样本量。
主要发现
- CDK19而非旁系同源物CDK8在小鼠HSC中相对富集,且增殖应激后CDK19表达增加比CDK8更显著。
- SenexinB(CDK8/19抑制剂)处理损害HSC的增殖与自我更新能力。
- CDK19过表达比CDK8过表达更好地促进HSC功能。
- CDK19-/- HSC表现出与SenexinB处理细胞相似的表型。
- CDK19缺失HSC中p53信号通路显著激活;CDK19与p53互作抑制p53介导的p21转录;p53特异性抑制剂PFTβ部分挽救CDK19缺失HSC的缺陷。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The cell cycle progression of hematopoietic stem cells (HSCs) and acute myeloid leukemia (AML) cells is precisely controlled by multiple regulatory factors. However, the underlying mechanisms are not fully understood. Here, we find that cyclin-dependent kinase 19 (CDK19), not its paralogue CDK8, is relatively enriched in mouse HSCs, and its expression is more significantly increased than CDK8 after proliferative stresses. Furthermore, SenexinB (a CDK8/19 inhibitor) treatment impairs the proliferation and self-renewal ability of HSCs. Moreover, overexpression of CDK19 promotes HSC function better than CDK8 overexpression. Using CDK19 knockout mice, we observe that CDK19-/- HSCs exhibit similar phenotypes to those of cells treated with SenexinB. Interestingly, the p53 signaling pathway is significantly activated in HSCs lacking CDK19 expression. Further investigations show that CDK19 can interact with p53 to inhibit p53-mediated transcription of p21 in HSCs and treatment with a specific p53 inhibitor (PFTβ) partially rescues the defects of CDK19-null HSCs. Importantly, SenexinB treatment markedly inhibits the proliferation of AML cells. Collectively, our findings indicate that CDK19 is involved in regulating HSC and AML cell proliferation via the p53-p21 pathway, revealing a new mechanism underlying cell cycle regulation in normal and malignant hematopoietic cells.
引用
- Zhang Z, Lu Y, Qi Y, et al. CDK19 regulates the proliferation of hematopoietic stem cells and acute myeloid leukemia cells by suppressing p53-mediated transcription of p21. Leukemia. 2022. PMID: 35110726. doi:10.1038/s41375-022-01512-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。